Evidence map›Paper›PMID 41213911›Full record

ArticleNature communications2025

A chromosome-level genome of Astilbe chinensis unveils the evolution of a terpene biosynthetic gene cluster.

Fangfang Chen, Yan Yao, Hangzhi Zhu, Jie Hu, Aohan Geng, Zhenni Xu, Xueting Fang, Weijia Cheng, Yao Zhi, Yonghong Zhang and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fangfang Chen *Department of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Yan Yao *Department of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Hangzhi ZhuDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Jie HuDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Aohan GengDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Zhenni XuDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Xueting FangDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Weijia ChengDepartment of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Yao ZhiWuhan Hesheng Technology Co., Ltd., Wuhan, Hubei, China.
Yonghong ZhangLaboratory of Medicinal Plant, Hubei University of Medicine, Shiyan, Hubei, China.
Zixin DengDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.ORCID http://orcid.org/0000-0003-0724-3390
Tiangang LiuSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0001-8087-0345
Li LuDepartment of Urology, Zhongnan Hospital of Wuhan University, Hubei Provincial Research Center for Basic Biological Science, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China. luliwhu@whu.edu.cn.ORCID http://orcid.org/0000-0003-0490-7163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astilbe chinensis, a perennial ornamental plant in the Saxifragaceae family, is recognized for its medicinal properties due to its diverse secondary metabolites. Here, we generate a chromosome-level genome assembly of A. chinensis. Our analysis provides compelling evidence that A. chinensis experienced a whole-genome triplication event, which preceded the diversification of the Saxifragaceae family. Furthermore, we identify a biosynthetic gene cluster that includes nine terpene synthase (TPS) genes. Among these, the gene AcTPS2 encodes a eudesma-5,7-diene synthase, and the product is confirmed using nuclear magnetic resonance spectroscopy. A synteny analysis of this gene cluster across various representative plant species reveals variations in the number, sequence, and function of TPS genes, indicating that neo-functionalization of these TPS genes likely occurred after speciation. Collectively, the genome sequence of A. chinensis lays the foundation for genetic and evolutionary studies of the Saxifragaceae family and provides insights into terpene synthases discovery.

Indexed as

Chromosomes, PlantEvolution, MolecularGenome, PlantMultigene FamilyTerpenesAlkyl and Aryl TransferasesBiosynthetic PathwaysPhylogenyPlant ProteinsSyntenyAlkyl and Aryl TransferasesPlant ProteinsTerpenesterpene synthase

Identifiers

PMID41213911
PMCPMC12602695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.